This content is from: Direct Tax

Taxpayers struggle with post-BEPS uncertainty over IP

The BEPS definition of intangibles has thrown businesses in the pharmaceutical sector, among others, into uncertainty.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial